HEHSF yields 4.30% · JNJ yields 2.13%● Live data
📍 HEHSF pulled ahead of the other in Year 1
Combined, HEHSF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HEHSF + JNJ for your $10,000?
Hellenic Exchanges - Athens Stock Exchange SA provides support services to the Greek capital market. It operates equities and derivatives markets, and the alternative market; performs clearing and settlement of trades; and offers financing tools and solutions. The company is involved in the management of clearing systems and/or central counterparty; and finalizing, reconciling, or settling the finalization of transactions in financial instruments, as well as operates as a system administrator in the Athens Exchange Clearing House. It engages in carrying out activities relating to the provision of central securities depository services, and ancillary or supplementary services. In addition, the company offers listing, trading, clearing, settlement, registry, and regulatory services. The company was formerly known as Hellenic Exchanges S.A. and changed its name to Hellenic Exchanges - Athens Stock Exchange SA in December 2013. Hellenic Exchanges - Athens Stock Exchange SA was founded in 1876 and is headquartered in Athens, Greece.
Full HEHSF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.